FREE AGENT

Brand Owner (click to sort) Address Description
FREEAGENT FREEAGENT NETWORK, INC. 20665 4TH STREET UNIT 204 SARATOGA CA 95070 FREE AGENT;Providing online non-downloadable software to store, manage, track, analyze and report data in the field of sales support, promotion, marketing, customer information and customer relationship management; application service provider (ASP) services featuring computer software for providing sales, customer service, customer information, customer relationship management and data analytics; software as a service (SAAS) services featuring software for providing sales, customer service, cloud computing, customer information, customer relationship management, data analytics, advertising and brand development; Computer services, namely, designing, developing, and maintaining computer software applications for others and consulting services related thereto; cloud computing services featuring computer software for use in uploading, downloading, posting, displaying, sharing or accessing remotely stored data, photographs, images, designs, audio, video, documents and other computer or electronic files via a global computer network; hosting online web facilities for other which allow the user to publish and share their own content;
FREEAGENT FREEAGENT NETWORK, INC. 20665 4TH STREET UNIT 204 SARATOGA CA 95070 FREE AGENT;Social networking services for businesses and individuals to exchange business leads of others via global computer network; social networking services to obtain business opportunities in the field of business analytics, sales and customer service via global computer network;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A specific binding agent is provided, wherein the specific binding agent specifically binds Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin-6 (vIL-6), and the specific binding agent neutralizes an activity of vIL-6. In one embodiment, the specific binding agent is an antibody. Methods are provided for using a specific binding agent that binds vIL-6, and neutralizes a biological activity of vIL-6. Methods of treatment for a KSHV-associated disorder are also provided. Methods for diagnosing a KSHV-associated disorder are provided, as are kits that include a specific binding agent of the invention. A method is also provided for testing an agent for effectiveness in treating a KSHV-associated disorder. The method includes incubating the agent with a cell free system comprising a vIL-6 receptor component and vIL-6, and comparing the binding of vIL-6 and the receptor component in the presence of the agent to binding of vIL-6 to the receptor component in the absence of the agent. A decrease in the binding of vIL-6 to the receptor component in the presence of the agent indicates that the agent is effective for treating the KSHV-associated disorder.